You are here

Article Text

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir
  1. Partha Das1,
  2. Vadamalai Vivek2,
  3. Martin Ford2,
  4. Edward Kingdon2,
  5. Stephen Holt3
  1. 1Department of Nephrology and Transplantation, Guy and St Thomas Hospitals, NHS Foundation Trust, London, UK
  2. 2Sussex Kidney Unit, Brighton and Sussex University Hospitals NHS Trust, Brighton, East Sussex, UK
  3. 3Monash University, Clayton, Victoria, Australia
  1. Correspondence to Dr Partha Das, parthadas{at}doctors.net.uk

Summary

Membranous glomerulonephritis is the most common histological renal lesion associated with hepatitis B virus (HBV) infection. The authors describe here a case of a patient presenting with the nephrotic syndrome and HBV infection but without progressive liver disease. The use of lamivudine and tenofovir resulted in arrest of proteinuria and stabilisation of renal function.

https://doi.org/10.1136/bcr.05.2011.4287

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None.

    • Patient consent Obtained.